PBAC Public Summary Documents - July 2005

Public Summary Documents relating to the July 2005 PBAC Meeting.

• Abacavir Sulfate with Lamivudine, tablet, 600 mg (base) - 300 mg, Kivexa®, July 2005
• Anastrozole, tablets, 1 mg, Arimidex®, July 2005
• Buprenorphine, transdermal patch, 5 mg, 10 mg and 20 mg (releasing 5 micrograms, 10 micrograms and 20 micrograms per hour respectively), Norspan®, July 2005
• Coal Tar Prepared , emulsion, 10 mg per g (1%), Exorex®, July 2005
• Docetaxel, injection set containing 1 single use vial concentrate for I.V. infusion, 20 mg (anhydrous) in 0.5 mL and 1 single use vial solvent 1.5 mL and 80 mg (anhydrous) in 2 mL and 1 single use vial solvent 6 mL, Taxotere, July 2005
• Efalizumab, injection set containing 4 vials powder for injection 125 mg and 4 pre-filled syringes solvent 1.3 mL, Raptiva®, July 2005
• Eplerenone, film-coated tablets, 25 mg, 50 mg, Inspra®, July 2005
• Etanercept, injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL, Enbrel ®, July 2005
• Ezetimibe with Simvastatin, tablet, 10 mg-40 mg, 10 mg-80 mg, Vytorin® , July 2005
• Hydromorphone Hydrochloride, extended release capsules, 12 mg, 16 mg , 24 mg, and 32 mg, Palladone® XL, July 2005
• Insulin Detemir (rys) cartridge 3mL (Penfill® ), prefilled device 3 mL (FlexPen®), 100U/mL, Levemir ®, July 2005
• Insulin Glargine, injection, 100 units per mL, 10 mL vials and 3 mL x 5 cartridges, Lantus® , July 2005
• Lanreotide Acetate, pre-filled syringe, 60 mg in 0.3mL (base), 90 mg in 0.3 mL (base) and 120 mg in 0.5 mL (base), Somatuline Autogel®, July 2005
• Latanoprost with Timolol Maleate, eye drops, 50 micrograms-5 mg (base) per mL (0.005%-0.5%), 2.5 mL, Xalacom®, July 2005
• Pregabalin, capsule, 75, 150 & 300 mg, Lyrica®, July 2005
• Risperidone, powder for I.M. injection, 25 mg, 37.5 mg and 50 mg (modified release) with 2 mL diluent in pre-filled syringe, Risperdal Consta®, July 2005
• Strontium Ranelate, sachet containing granules for oral suspension, 2g, Protos®, July 2005
• Teriparatide, solution for injection, in a 3mL cartridge contained in a pre-filled disposable delivery device (pen), 250 micrograms/mL, Forteo, July 2005

Page last updated: 28 October 2005